Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Berry Oncology Partners with Alibaba Health to Create China's Early Cancer Screening Ecosystem 2021-06-21 21:00
I-Mab Appoints International Gastrointestinal Oncology Expert Dr. Andrew Zhu to its Scientific Advisory Board 2021-06-21 20:00
TIAN RUIXIANG Holdings Ltd Steps into Healthcare Management Industry 2021-06-21 20:00
Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test 2021-06-21 19:27
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL. 2021-06-20 21:00
InnoCare Presents Latest Clinical Data of Orelabrutinib at the16th International Conference on Malignant Lymphoma 2021-06-18 17:12
RBC Expands Global Youth Charity Program - RBC Charity Day for the Kids 2021-06-17 20:00
Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC 2021-06-17 15:41
InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma 2021-06-17 11:31
Spark Aligners Does It Again With Market Leading Innovation And New FDA Approval To Give Doctors Greater Control And Flexibility 2021-06-16 20:45
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment 2021-06-16 13:08
 Smith+Nephew launches Real Intelligence and CORI™ Surgical System, next generation robotics platform, in Australia and New Zealand 2021-06-16 06:00
VNTC confirms Dong-A ST its sole distributor of scoliosis brace Spinamic in South Korea 2021-06-16 00:00
Frontera Therapeutics Starts GMP Manufacturing Facility Construction 2021-06-15 23:32
BIO Digital Taiwan Day will be held on June 22 2021-06-15 23:00
Kazia Enters Clinical Collaboration With Cornell University for Phase II Clinical Study Using Paxalisib in Combination With Ketogenic Diet for Glioblastoma 2021-06-15 22:00
The U.S. FDA Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2021-06-15 08:46
Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab 2021-06-14 15:00
Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis 2021-06-14 06:00
ImmVira completed the first dosing for Phase II of MVR-T3011 (intratumoral injection) in the U.S. and China 2021-06-12 11:16
1 142 143 144 145 146 404